[1]
|
Saeedi, P., Petersohn, I., Salpea, P., et al. (2019) Global and Regional Diabetes Prevalence Estimates for 2019 and Pro-jections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th Edition. Diabetes Re-search and Clinical Practice, 157, Article ID: 107843. https://doi.org/10.1016/j.diabres.2019.107843
|
[2]
|
Sun, H., Saeedi, P., Karuranga, S., et al. (2022) IDF Diabetes Atlas: Global, Regional and Country-Level Diabetes Prevalence Es-timates for 2021 and Projections for 2045. Diabetes Research and Clinical Practice, 183, Article ID: 109119. https://doi.org/10.1016/j.diabres.2021.109119
|
[3]
|
NCD Risk Factor Collaboration (NCD-RisC) (2017) World-wide Trends in Body-Mass Index, Underweight, Overweight, and Obesity from 1975 to 2016: A Pooled Analysis of 2416 Population-Based Measurement Studies in 1289 Million Children, Adolescents, and Adults. The Lancet, 390, 2627-2642.
|
[4]
|
Alberti, K.G. and Zimmet, P.Z. (1998) Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus Provisional Report of a WHO Consulta-tion. Diabetic Medicine, 15, 539-553. https://doi.org/10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
|
[5]
|
Inzucchi, S.E., Ber-genstal, R.M., Buse, J.B., et al. (2012) Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care, 35, 1364-1379. https://doi.org/10.2337/dc12-0413
|
[6]
|
Chung, W.K., Erion, K., Florez, J.C., et al. (2020) Precision Medicine in Diabetes: A Consensus Report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care, 43, 1617-1635. https://doi.org/10.2337/dci20-0022
|
[7]
|
Nolan, J.J., Kahkoska, A.R., Semnani-Azad, Z., et al. (2022) ADA/EASD Precision Medicine in Diabetes Initiative: An International Perspective and Future Vision for Precision Medicine in Dia-betes. Diabetes Care, 45, 261-266.
https://doi.org/10.2337/dc21-2216
|
[8]
|
Tobias, D.K., Merino, J., Ahmad, A., et al. (2023) Second International Consensus Report on Gaps and Opportunities for the Clinical Translation of Precision Diabetes Medicine. Nature Medi-cine, 29, 2438-2457.
https://doi.org/10.1038/s41591-023-02502-5
|
[9]
|
Nkonge, K.M., Nkonge, D.K. and Nkonge, T.N. (2020) The Epidemiology, Molecular Pathogenesis, Diagnosis, and Treatment of Maturity-Onset Diabetes of the Young (MODY). Clinical Diabetes and Endocrinology, 6, Article No. 20. https://doi.org/10.1186/s40842-020-00112-5
|
[10]
|
Laver, T.W., Wakeling, M.N., et al. (2022) Evaluation of Evidence for Pathogenicity Demonstrates That BLK, KLF11, and PAX4 Should Not Be Included in Diagnostic Testing for MODY. Diabetes, 71, 1128-1136.
https://doi.org/10.2337/db21-0844
|
[11]
|
Forlani, G., Zucchini, S., Di Rocco, A., et al. (2010) Double Heterozygous Mutations Involving Both HNF1A/MODY3 and HNF4A/MODY1 Genes: A Case Report. Diabetes Care, 33, 2336-2338. https://doi.org/10.2337/dc10-0561
|
[12]
|
Kant, R., Davis, A. and Verma, V. (2022) Maturity-Onset Di-abetes of the Young: Rapid Evidence Review. American Family Physician, 105, 162-167.
|
[13]
|
Broome, D.T., Pantalone, K.M., Kashyap, S.R. and Philipson, L.H. (2021) Approach to the Patient with MODY- Monogenic Diabetes. The Jour-nal of Clinical Endocrinology and Metabolism, 106, 237-250.
https://doi.org/10.1210/clinem/dgaa710
|
[14]
|
Li, J., Shu, M., Wang, X., et al. (2021) Precision Therapy for a Chi-nese Family with Maturity-Onset Diabetes of the Young. Frontiers in Endocrinology, 12, Article 700342. https://doi.org/10.3389/fendo.2021.700342
|
[15]
|
Kahraman, S., Dirice, E., Basile, G., et al. (2022) Abnormal Exo-crine-Endocrine Cell Cross-Talk Promotes β-Cell Dysfunction and Loss in MODY8. Nature Metabolism, 4, 76-89. https://doi.org/10.1038/s42255-021-00516-2
|
[16]
|
(1965) Diabetes Mellitus. Report of a WHO Expert Committee. World Health Organization Technical Report Series, 310, 1-44.
|
[17]
|
(1980) WHO Expert Committee on Diabetes Mellitus: Second Report. World Health Organization Technical Report Series, 646, 1-80.
|
[18]
|
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus; Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, 20, 1183-1197. https://doi.org/10.2337/diacare.20.7.1183
|
[19]
|
World Health Organization (2019) Classifica-tion of Diabetes Mellitus, 2019. WHO Document Production Services, Geneva.
|
[20]
|
Brooks-Worrell, B.M., Reichow, J.L., Goel, A., Ismail, H. and Palmer, J.P. (2011) Identification of Autoantibody- Negative Autoimmune Type 2 Diabetic Patients. Diabetes Care, 34, 168-173. https://doi.org/10.2337/dc10-0579
|
[21]
|
Liang, H., Cheng, Y., Tang, W., et al. (2019) Clinical Manifestation and Islet β-Cell Function of a Subtype of Latent Autoimmune Diabetes in Adults (LADA): Positive for T Cell Responses in Phenotypic Type 2 Diabetes. Acta Diabetologica, 56, 1225-1230. https://doi.org/10.1007/s00592-019-01391-w
|
[22]
|
McKeigue, P.M., Spiliopoulou, A., McGurnaghan, S., et al. (2019) Persistent C-Peptide Secretion in Type 1 Diabetes and Its Relationship to the Genetic Architecture of Diabetes. BMC Medicine, 17, Article No. 165.
https://doi.org/10.1186/s12916-019-1392-8
|
[23]
|
Buzzetti, R., Di Pietro, S., Giaccari, A., et al. (2007) High Titer of Autoantibodies to GAD Identifies a Specific Phenotype of Adult-Onset Autoimmune Diabetes. Diabetes Care, 30, 932-938. https://doi.org/10.2337/dc06-1696
|
[24]
|
Zhou, Z., Xiang, Y., Ji, L., et al. (2013) Frequency, Immunoge-netics, and Clinical Characteristics of Latent Autoimmune Diabetes in China (LADA China Study): A Nationwide, Mul-ticenter, Clinic-Based Cross-Sectional Study. Diabetes, 62, 543-550. https://doi.org/10.2337/db12-0207
|
[25]
|
Ahlqvist, E., Storm, P., Käräjämäki, A., et al. (2018) Novel Subgroups of Adult-Onset Diabetes and Their Association with Outcomes: A Data-Driven Cluster Analysis of Six Variables. The Lancet Diabetes & Endocrinology, 6, 361-369.
https://doi.org/10.1016/S2213-8587(18)30051-2
|
[26]
|
Bennet, L., Nilsson, C., Mansour-Aly, D., et al. (2021) Adult-Onset Diabetes in Middle Eastern Immigrants to Sweden: Novel Subgroups and Diabetic Complications—The All New Diabetes in Scania Cohort Diabetic Complications and Ethnicity. Diabetes/Metabolism Research and Reviews, 37, e3419. https://doi.org/10.1002/dmrr.3419
|
[27]
|
Fedotkina, O., Sulaieva, O., Ozgumus, T., et al. (2021) Novel Re-classification of Adult Diabetes Is Useful to Distinguish Stages of β-Cell Function Linked to the Risk of Vascular Com-plications: The DOLCE Study from Northern Ukraine. Frontiers in Genetics, 12, Article 637945. https://doi.org/10.3389/fgene.2021.637945
|
[28]
|
Zou, X., Zhu, Z. and Ji, L. (2019) Novel Subgroups of Patients with Adult-Onset Diabetes in Chinese and US Populations. The Lancet Diabetes & Endocrinology, 7, 9-11. https://doi.org/10.1016/S2213-8587(18)30316-4
|
[29]
|
Slieker, R.C., Donnelly, L.A., Fitipaldi, H., et al. (2021) Replication and Cross-Validation of Type 2 Diabetes Subtypes Based on Clinical Variables: An IMI-RHAPSODY Study. Diabetologia, 64, 1982-1989.
https://doi.org/10.1007/s00125-021-05490-8
|
[30]
|
Prasad, R.B., Asplund, O., et al. (2022) Subgroups of Patients with Young-Onset Type 2 Diabetes in India Reveal Insulin Deficiency as a Major Driver. Diabetologia, 65, 65-78. https://doi.org/10.1007/s00125-021-05543-y
|
[31]
|
Xiong, X.F., Yang, Y., Wei, L., et al. (2021) Identification of Two Novel Subgroups in Patients with Diabetes Mellitus and Their Association with Clinical Outcomes: A Two-Step Cluster Analysis. Journal of Diabetes Investigation, 12, 1346-1358. https://doi.org/10.1111/jdi.13494
|
[32]
|
Herder, C., Maalmi, H., Strassburger, K., et al. (2021) Differences in Biomarkers of Inflammation between Novel Subgroups of Recent-Onset Diabetes. Diabetes, 70, 1198-1208. https://doi.org/10.2337/db20-1054
|
[33]
|
Udler, M.S., Kim, J., Von Grotthuss, M., et al. (2018) Type 2 Diabetes Genetic Loci Informed by Multi-Trait Associations Point to Disease Mechanisms and Subtypes: A Soft Clustering Analysis. PLOS Medicine, 15, e1002654.
https://doi.org/10.1371/journal.pmed.1002654
|
[34]
|
Schwartz, S.S., Epstein, S., Corkey, B.E., et al. (2016) The Time Is Right for a New Classification System for Diabetes: Rationale and Implications of the β-Cell-Centric Classifica-tion Schema. Diabetes Care, 39, 179-186.
https://doi.org/10.2337/dc15-1585
|